Keenan, C M <br/><br/>
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner.  [electronic resource] 

 -  British journal of pharmacology  May 2015 
 - 2406-18 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5381 
<br/><br/><label>Standard No.: </label>10.1111/bph.13069  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Body Temperature Regulation--drug effects<br/>CA1 Region, Hippocampal--drug effects<br/>CA2 Region, Hippocampal--drug effects<br/>CA3 Region, Hippocampal--drug effects<br/>Cannabinoid Receptor Agonists--pharmacology<br/>Cells, Cultured<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Dronabinol--analogs & derivatives<br/>Enteric Nervous System--drug effects<br/>Gastrointestinal Motility--drug effects<br/>Hypothermia--drug therapy<br/>Intestinal Mucosa--metabolism<br/>Intestines--drug effects<br/>Ligands<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Motor Activity--drug effects<br/>Pain--drug therapy<br/>Pain Threshold--drug effects<br/>Receptor, Cannabinoid, CB1--agonists<br/>Receptor, Cannabinoid, CB2--genetics<br/>Stress, Psychological--drug therapy<br/>Time Factors